However, the bacterial strain components of the Respecta® complex (La-14 and HN001) have been reported to have an alike or enhanced efficacy compared to the combination of La-14, HN001, and lactoferrin in attenuating G. vaginalis-induced BV in mice, in inhibiting G. vaginalis growth, and in adherence to human HeLa cells in vitro [38], suggesting that lactoferrin is not essential for efficacy. Here, LTF is linked to bacterial vaginosis.